Inventor
GARFIELD ROBERT E
US35 patents
⚠️ This page may combine multiple inventors who share the name “GARFIELD ROBERT E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
11 patentsUS5789442AAug 4, 1998
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
SCHERING AG135 citations99
US6356777B1Mar 12, 2002
Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervix
SCHERING AG56 citations96
US6040340AMar 21, 2000
Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
SCHERING AG86 citations96
US5595970AJan 21, 1997
Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
SCHERING AG97 citations95
US6028106AFeb 22, 2000
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
SCHERING AG23 citations92
US5906987AMay 25, 1999
Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
SCHERING AG40 citations92
US5895783AApr 20, 1999
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
SCHERING AG34 citations89
US5962413AOct 5, 1999
Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
SCHERING AG10 citations73
US5948762ASep 7, 1999
Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor
SCHERING AG7 citations73
US6333350B1Dec 25, 2001
Use of nitric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility
SCHERING AG3 citations63
US5958878ASep 28, 1999
Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
SCHERING AG1 citations51
UNIV TEXAS
11 patentsUS5811416ASep 22, 1998
Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
UNIV TEXAS122 citations98
US5623939AApr 29, 1997
Method and apparatus for analyzing uterine electrical activity from surface measurements for obstetrical diagnosis
UNIV TEXAS129 citations98
US5546953AAug 20, 1996
Method and apparatus for the recording and analysis of uterine electrical activity from the abdominal surface
UNIV TEXAS88 citations96
US5776073AJul 7, 1998
Method and apparatus for analyzing uterine electrical activity from surface measurements for obstetrical diagnosis
UNIV TEXAS167 citations94
US6613757B1Sep 2, 2003
Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
UNIV TEXAS19 citations92
US5965529AOct 12, 1999
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
UNIV TEXAS20 citations92
US5698738ADec 16, 1997
N-nitroso-N-substituted hydroxylamines as nitric oxide donors
UNIV TEXAS79 citations92
US5643944AJul 1, 1997
Ovulation control by regulating nitric oxide levels
UNIV TEXAS25 citations92
US5721278AFeb 24, 1998
Ovulation control by regulating nitric oxide levels
UNIV TEXAS13 citations81
US5470847ANov 28, 1995
Ovulation control by regulating nitric oxide levels with arginine derivatives
UNIV TEXAS12 citations73
US6844320B1Jan 18, 2005
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
UNIV TEXAS3 citations62
DIGNITY HEALTH
5 patentsUS9872983B2Jan 23, 2018
Uterine electrical stimulation system and method
DIGNITY HEALTH4 citations65
US11058900B2Jul 13, 2021
Methods and apparatus for treating a cervix with ultrasound energy
DIGNITY HEALTH1 citations60
US10328254B2Jun 25, 2019
Uterine electrical stimulation system and method
DIGNITY HEALTH0 citations50
US9572972B2Feb 21, 2017
Uterine electrical stimulation system and method
DIGNITY HEALTH0 citations50
US10555955B2Feb 11, 2020
Trimegestone (TMG) for treatment of preterm birth
DIGNITY HEALTH0 citations48
GARFIELD ROBERT E
4 patentsUS8972028B2Mar 3, 2015
Uterine electrical stimulation system and method
GARFIELD ROBERT E14 citations89
US8606371B2Dec 10, 2013
Uterine electrical stimulation system and method
GARFIELD ROBERT E17 citations89
US9731120B2Aug 15, 2017
Uterine electrical stimulation system and method
GARFIELD ROBERT E3 citations70
US9271991B2Mar 1, 2016
Trimegestone (TMG) for treatment of preterm birth
GARFIELD ROBERT E0 citations46